Clinical Trials
319 trialsPRSTEC_multipr
University Hospital Hradec Kralove
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Tampere University Hospital
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
M.D. Anderson Cancer Center
V-COSMOS
Cukurova University
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
AstraZeneca
Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding
University of Aarhus
DUOLife
AstraZeneca
GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
University of Southern California
MIRA
University of British Columbia
GEORGIA
Ohio State University Comprehensive Cancer Center
LPSvsLPT
Azienda USL Reggio Emilia - IRCCS
iCaRe2
University of Nebraska
DP-04
AstraZeneca
ENDOCancerDATA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ELEPHAS-02
Elephas
REPLACE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
LYNX-EYE
San Raffaele University
ENVISION
Exact Sciences Corporation
ECHO
Mayo Clinic
DETECTR
University of British Columbia
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
M.D. Anderson Cancer Center
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Mayo Clinic
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Mayo Clinic
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Memorial Sloan Kettering Cancer Center
Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center
ASAP
Avera McKennan Hospital & University Health Center
(CLOCS-2)
Imperial College London
ELEPHAS-04
Mayo Clinic
Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
M.D. Anderson Cancer Center
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Tata Memorial Hospital
Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer
M.D. Anderson Cancer Center
IREN
AstraZeneca
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Mayo Clinic
ESG-ENDO
Centro di Riferimento Oncologico - Aviano
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
University Hospital Tuebingen
IMPACTEndoAsia
Tata Memorial Hospital
DOSTCONICG
Cukurova University
Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
Asan Medical Center
Diet, Hepcidin, and Chemotherapy RDI
George Washington University
SMARAGD
iOMEDICO AG
The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
University of Aarhus
CAMPERR
Adela, Inc
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
M.D. Anderson Cancer Center
ELEPHAS-05
Elephas
EndoMethy-V
Peking Union Medical College Hospital
Targeting Inflammation for Endometrial Cancer Prevention
Mayo Clinic
Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
National Cancer Institute, Naples
organoids endo
Regina Elena Cancer Institute
HERGYN
Daiichi Sankyo